Mark Lawler
Queen's University Belfast · 532 works · 11,460 citations · h-index 57
Top works
- Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study
- Autosomal dominant retinitis pigmentosa (ADRP): Localization of an ADRP gene to the long arm of chromosome 3
- Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
- Chimaerism following allogeneic bone marrow transplantation: detection of residual host cells using the polymerase chain reaction
- Aggressive treatment of ruptured abdominal aortic aneurysm in a community hospital.
- Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction
- Integrating Genomics into Healthcare: A Global Responsibility
- Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions
- Activated protein C inhibits lipopolysaccharide‐induced nuclear translocation of nuclear factor κB (NF‐κB) and tumour necrosis factor α (TNF‐α) production in the THP‐1 monocytic cell line
- Autosomal dominant retinitis pigmentosa: Linkage to rhodopsin and evidence for genetic heterogeneity
- Delivering modern, high-quality, affordable pathology and laboratory medicine to low-income and middle-income countries: a call to action
- Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.
- Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study
- Facilitating a culture of responsible and effective sharing of cancer genome data
- European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
- The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study
- Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy
- A Catalyst for Change: The European Cancer Patient's Bill of Rights
- Donor-Cell Leukemia after Bone Marrow Transplantation for Severe Aplastic Anemia
- Expression of the NF‐κB targets BCL2 and BIRC5/Survivin characterizes small B‐cell and aggressive B‐cell lymphomas, respectively